(Q34178322)
Statements
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes (English)
A P S Kong
A Yamasaki
R Ozaki
H Saito
T Asami
S Ohwada
G T C Ko
C K Wong
G T C Leung
K F Lee
1 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference